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	 How	effective	are	opioids		
for	chronic	low	back	pain?
	 Short-term	 (<4	 months)	 treat-	
	 ment	with	opioids	provides	mod-
est	relief	of	chronic	low	back	pain,	but	only	
minimal	 improvement	 in	 function	 com-
pared	 with	 placebo	 (strength	 of	 recom-
mendation	 [SOR]:	B,	 systematic	 review	of	
lower-quality	randomized	controlled	trials	
[RCTs]).	
Tramadol	 isn’t	 superior	 to	nonsteroi-
dal	anti-inflammatory	drugs	(NSAIDs)	 for	
pain	relief	(SOR:	A,	consistent	results	from	
RCTs).	In	addition,	oxycodone	with	titrated	
morphine	 isn’t	 better	 than	 naproxen	 for	
relieving	pain	or	improving	function	(SOR:	
C,	a	low-quality	RCT).	
Although	 no	 long-term	 RCTs	 have	
been	done,	cohort	studies	have	shown	that	
6	to	12	months	of	opioid	use	is	associated	
with	 a	 small	 decrease	 in	 pain	 and	 either	
very	minimal	improvement	in,	or	worsen-
ing	 of,	 disability	 (SOR:	B,	 prospective	 co-
hort	trials).
evidence summary
A	 systematic	 review	 and	 meta-analysis	 of	
15	RCTs	with	a	 total	enrollment	of	5540	as-
sessed	the	efficacy	of	opioids	in	adults	with	
chronic	 low	back	pain	of	 at	 least	 12	weeks’	
duration.1	Five	low-quality	studies	(1378	pa-
tients)	that	compared	tramadol	with	placebo	
found	tramadol	to	be	moderately	superior	to	
placebo	 for	 relieving	 pain	 (standard	 mean	
difference	[SMD]=	-0.55;	95%	confidence	in-
terval	[CI],	-0.66	to	-0.44)	but	only	modestly	
better	for	 improving	function	(SMD=	−0.18;	
95%	CI,	-0.29	to	-0.07).	
Six	 trials	 with	 1887	 patients	 compared	
strong	 opioids	 (morphine,	 hydromorphone,	
oxycodone,	 oxymorphone,	 and	 tapentadol)	
with	placebo.	The	opioids	were	better	than	pla-
cebo	for	improving	pain	(SMD=	-0.43;	95%	CI,	
-0.52	to	-0.33)	and	function	(SMD=	-0.26;	95%	
CI,	 -0.37	 to	 -0.15).	The	 general	 interpretation	
of	 SMD	effect	 size	 is	 0.2=small,	 0.5=medium,	
0.8=large.	In	this	case,	larger	negative	numbers	
correlate	with	greater	improvement.	
How opioids stack up  
against NSAIDs
Two	separate	double-blind,	double-dummy	
studies	 randomized	 adults	 with	 low	 back	
pain	 of	 at	 least	 12	 weeks’	 duration	 to	 re-
ceive	celecoxib	200	mg	twice	daily	(404	and	
398	patients,	respectively)	or	tramadol	50	mg	
4	 times	daily	 (392	and	404	patients,	 respec-
tively)	 for	 6	weeks.2	 	 	The	primary	 outcome	
measure	was	at	least	a	30%	improvement	in	
pain	using	a	0	(no	pain)	to	10	(worst	possible	
pain)	 scale.	 In	 both	 studies,	 more	 patients	
taking	celecoxib	had	positive	responses	than	
patients	taking	tramadol	(63%	vs	50%,	P<.001,	
and	64%	vs	55%,	P<.008,	respectively).		
A	 small	 RCT	 (36	 patients	 who	 had	 suf-
fered	low	back	pain	for	more	than	6	months)	
randomized	 patients	 to	 one	 of	 3	 treatment	
groups	 for	16	weeks:	oxycodone	as	much	as	
20	 mg/d	 (13	 patients);	 naproxen	 as	 much	
as	 1	 g/d	 (12	 patients);	 or	 oxycodone	 and	
sustained-release	 morphine	 (titrated	 up	 to	
200	mg	morphine	equivalent/d	(11	patients).3	
After	16	weeks,	patients	receiving	oxycodone	
or	 naproxen	 were	 treated	 with	 oxycodone	
and	sustained-release	morphine	for	another	
16	weeks,	as	were	patients	already	receiving	
this	therapy.	Pain	was	assessed	on	a	0	(none)	
to	100	(worst	possible	pain)	scale.	
Both	opioid	groups	had	significantly	less	
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pain	on	average	(59.8	for	oxycodone,	54.9	for	
titrated	morphine)	 than	 the	 naproxen	 group	
(65.5;	F=16.07;	P<.001)	but	no	significant	dif-
ference	 in	 activity	 level.	 However,	 an	 inde-
pendent	 analysis	 of	 the	 naproxen	 group	 and	
titrated	morphine	group	found	no	significant	
difference	 in	 either	 pain	 relief	 (SMD=	 -0.58;	
95%	CI,	-1.42	to	0.26)	or	disability	(SMD=	-0.06;	
95%	CI,	-0.88	to	0.76)	between	the	2	groups.4	
How does long-term opioid use  
affect pain and function?
Two	prospective	cohort	studies	have	evaluated	
long-term	opioid	use.	The	first	 (715	patients)	
used	 a	 Roland-Morris	 Disability	 Question-
naire	(RMDQ)	to	assess	disability	at	6	months	
in	patients	taking	opioids	compared	with	pa-
tients	not	 taking	opioids.5	Patients	using	opi-
oids	 showed	 an	 increase	 in	 RMDQ	 score	 of	
1.18	units	(95%	CI,	0.17-2.19)	on	a	0	to	24	scale,	
with	24	representing	greatest	disability.	
The	 second	 study	 evaluated	 pain	 and	
function	in	1843	adults	with	acute	back	inju-
ries	taking	opioids	for	a	year.6	Pain,	rated	on	a	
0	to	10	scale,	decreased	from	7.7	at	baseline	to	
6.8	at	one	year	(no	P	value).	At	the	end	of	the	
first	quarter,	the	RMDQ	score	decreased	from	
18.8	at	baseline	(the	end	of	the	first	quarter)	
to	 17.5	 at	 one	 year	 (no	 P	 value).	 Clinically	
meaningful	 improvement	 in	 pain	 and	 func-
tion	(30%	or	more)	occurred	in	26%	(95%	CI,	
18%-36%)	and	16%	(95%	CI,	10%-25%)	of	pa-
tients,	respectively.	
Recommendations
The	 2007	 clinical	 practice	 guideline	 on	 low	
back	pain	from	The	American	College	of	Physi-
cians	and	American	Pain	Society	recommends	
opioids,	including	tramadol,	for	patients	with	
severe	back	pain	who	don’t	get	adequate	relief	
from	acetaminophen	or	NSAIDs.7	
The	 2009	 National	 Institute	 for	 Health	
and	 Care	 Excellence	 (NICE)	 guidelines	 for	
early	 management	 of	 persistent,	 nonspe-
cific	 low	back	pain	 recommend	considering	
strong	opioids	(buprenorphine,	fentanyl,	and	
oxycodone)	for	short-term	use	in	severe	pain	
and	referral	to	a	specialist	for	patients	requir-
ing	prolonged	use	of	strong	opioids.8	
The	2013	British	Pain	Society	guidelines	
for	low	back	and	radicular	pain	recommend	
tight	restrictions	on	the	use	of	strong	opioids.	
They	also	recommend	giving	the	lowest	pos-
sible	 dose	 of	 opioids	 for	 the	 shortest	 time	
possible.9		 	 	 													JFP
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